desmopressin acetate


Also found in: Medical, Acronyms, Wikipedia.
Related to desmopressin acetate: diabetes insipidus

des·mo·pres·sin acetate

 (dĕs′mə-prĕs′ĭn)
n.
A synthetic analog of vasopressin used therapeutically as an antidiuretic and in the management of bleeding in individuals with some forms of hemophilia and von Willebrand disease.

[des(a)m(in)o-, lacking an amine group (des-, variant of de- + amino-) + (vaso)pressin.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Desmopressin acetate is capable of significantly reducing blood loss and thus minimising the haemorrhagic risk [12, 14, 20].
Hematology consultation was obtained for the administration of desmopressin acetate (DDAVP) for correction of her platelet function after which she underwent an uncomplicated primary cesarean section.
Here, a very low birth weight premature infant who developed central diabetes insipidus secondary to pituitary hemorrhage in the newborn period and was treated successfully with intranasal desmopressin acetate was presented.
Desmopressin acetate, a synthetic analogue of the natural pituitary hormone ADH, is used in the management of central diabetes insipidus.
Eleven of 19 patients treated with aminocaproic acid, desmopressin acetate, or oral contraceptives achieved menstrual control.
Intranasal formulations of desmopressin acetate are no longer indicated for treating primary nocturnal enuresis because of the risk of severe hyponatremia and seizures associated with these products when used for this indication, according to the Food and Drug Administration.
BY ELIZABETH MECHCATIE Senior Writer Intranasal formulations of desmopressin acetate are no longer indicated for treating primary nocturnal enuresis because of the risk of severe hyponatremia and seizures associated with these products when used for this indication, according to the Food and Drug Administration.
Some patients with von Willebrand Disease and some patients with mild hemophilia A may respond to desmopressin acetate (DDAVP), a synthetic hormone.
These include moisture-sensing alarms and motivational therapies, as well as pharmacologic options such as desmopressin acetate. As health care professionals, we can make a difference.
This study was performed at the animal Physiology Laboratory of the Universidad del Zulia in Veterinary School, Maracaibo, Zulia state, Venezuela, in order to make a comparison between the Desmopressin acetate and neurohipophyseal extract of bovine, with 24 adult toads, placed in water to guaranty over hydration and a physiological inhibition of Endogenous vasopressin release.
The most successive drug in treating nocturnal enuresis is desmopressin acetate, sold as DDAVP.
Desmopressin acetate (DDAVP) is an increasingly used, well-tolerated medicine for the treatment of primary nocturnal enuresis and central diabetes insipidus.